Found 5 matching trials
Ibrutinib and Lenalidomide With Dose Adjusted EPOCH-R in Subjects With Relapsed/Refractory Diffuse Large B-cell Lymphoma
PHASE1This is a Phase 1b/2, open-label, non-randomized multicenter study to asses...
Smart Start: A Phase II Study of Rituximab, Lenalidomide, and Ibrutinib
PHASE2This phase II trial studies how well giving rituximab, lenalidomide, and ib...
Location
M D Anderson Cancer Center
Evaluation of Risk-Adapted and MRD-Driven Strategy for Untreated Fit Patients With Intermediate Risk Chronic Lymphocytic Leukemia
PHASE2The aim of this study is to test the potential benefit of an innovative com...
Location
CH Annecy Genevois - Hématologie A3
Real World Data on Ibrutinib Use in PCNSL Rel/Ref
N/APCNSL is a rare and aggressive subtype of B lymphoma that has been recogniz...
Status
Active Not Recruiting
Location
Ospedale San Raffaele
R-EPOCH in Combination With Ibrutinib for Patients With Classical RT of CLL
PHASE2This is an investigator-initiated Phase 2 study, which combines R-EDOCH wit...
Location
Peking university Third Hospital